Trends in Nontherapeutic Laparotomy Rates in Patients Undergoing Surgical Therapy for Hepatic Colorectal Metastases

被引:25
作者
Pawlik, Timothy M. [1 ]
Assumpcao, Lia [1 ]
Vossen, Josephina A. [1 ]
Buijs, Manon [1 ]
Gleisner, Ana L. [1 ]
Schulick, Richard D. [1 ]
Choti, Michael A. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Surg, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
POSITRON-EMISSION-TOMOGRAPHY; LIVER METASTASES; DIAGNOSTIC LAPAROSCOPY; RANDOMIZED-TRIAL; RADIOFREQUENCY ABLATION; FLUOROURACIL FAILURE; COMPUTED-TOMOGRAPHY; STAGING LAPAROSCOPY; CONTINUOUS-INFUSION; RESECTION;
D O I
10.1245/s10434-008-0230-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgery is the treatment of choice in selected patients with hepatic colorectal metastases. Despite improvements in preoperative imaging, patients can undergo unnecessary nontherapeutic laparotomy. The aim of this study was to examine trends in nontherapeutic laparotomy rates in patients undergoing planned surgical therapy for hepatic colorectal metastases. Data from 530 operations (461 patients) undergoing potentially curative surgical therapy for colorectal liver metastases between 1994 and 2005 were analyzed. The incidence of nontherapeutic laparotomy was determined and factors associated with nontherapeutic laparotomy were identified. Overall, 49 nontherapeutic laparotomies were performed (9.2%). Higher nontherapeutic laparotomy rates were seen in patients with multiple metastases and tumor size > 5 cm (both P < 0.05). Preoperative positron emission tomography (PET) imaging was associated with lower risk of nontherapeutic laparotomy [5.6% versus 12.4%, P = 0.009, odds ratio (OR) = 0.42]. At laparotomy, extrahepatic findings were the reason for nontherapeutic laparotomy in 44.9% of cases. The nontherapeutic laparotomy rate significantly decreased over time (14.9% for 1994-1997 versus 9.6% for 1998-2001 versus 4.7% for 2002-2005; P = 0.003). While patients in each time period were similar with regard to tumor specific factors, utilization of PET imaging (P < 0.001) as well as resection plus ablation (P = 0.004) increased over time. We conclude that prevalence of nontherapeutic laparotomy for patients undergoing surgical exploration for hepatic colorectal metastases has decreased significantly in recent years to less than 5%. The reasons for this trend are probably multifactorial and may include improved preoperative assessment, such as PET imaging, as well as salvage surgical options.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 45 条
  • [1] Akiyoshi T, 2008, COLORECTAL DIS
  • [2] [Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
  • [3] Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT
    Bartolozzi, C
    Donati, F
    Cioni, D
    Procacci, C
    Morana, G
    Chiesa, A
    Grazioli, L
    Cittadini, G
    Cittadini, G
    Giovagnoni, A
    Gandini, G
    Maass, J
    Lencioni, R
    [J]. EUROPEAN RADIOLOGY, 2004, 14 (01) : 14 - 20
  • [4] Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases
    Bennett, JJ
    Cao, DC
    Posner, MC
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (01) : 64 - 69
  • [5] POTENTIALLY RESECTABLE PANCREATIC ADENOCARCINOMA - SPIRAL CT ASSESSMENT WITH SURGICAL AND PATHOLOGICAL CORRELATION
    BLUEMKE, DA
    CAMERON, JL
    HRUBAN, RH
    PITT, HA
    SIEGELMAN, SS
    SOYER, P
    FISHMAN, EK
    [J]. RADIOLOGY, 1995, 197 (02) : 381 - 385
  • [6] Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases
    Choti, Michael A.
    Kaloma, Fanta
    de Oliveira, Michelle L.
    Nour, Samah
    Garrett-Mayer, Elizabeth S.
    Sheth, Sheila
    Pawlik, Timothy M.
    [J]. ARCHIVES OF SURGERY, 2008, 143 (01) : 29 - 34
  • [7] Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
    Cunningham, D
    Pyrhönen, S
    James, RD
    Punt, CJA
    Hickish, TF
    Heikkila, R
    Johannesen, TB
    Starkhammar, H
    Topham, CA
    Awad, L
    Jacques, C
    Herait, P
    [J]. LANCET, 1998, 352 (9138) : 1413 - 1418
  • [8] Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
    deGramont, A
    Basset, JF
    Milan, C
    Rougier, P
    Bouche, O
    Etienne, PL
    Morvan, F
    Louvet, C
    Guillot, C
    Francois, E
    Bedenne, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 808 - 815
  • [9] Echogenic appearance of colorectal liver metastases on intraoperative ultrasonography is associated with survival after hepatic resection
    DeOliveira, Michelle L.
    Pawlik, Timothy M.
    Gleisner, Ana L.
    Assumpcaom, Lia
    Lopes-Filho, Gaspar J.
    Choti, Michael A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (08) : 970 - 976
  • [10] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
    Douillard, JY
    Cunningham, D
    Roth, AD
    Navarro, M
    James, RD
    Karasek, P
    Jandik, P
    Iveson, T
    Carmichael, J
    Alakl, M
    Gruia, G
    Awad, L
    Rougier, P
    [J]. LANCET, 2000, 355 (9209) : 1041 - 1047